Seagull Technologies has developed a novel cross-platform drug delivery method that

non-invasively delivers drugs ranging from small molecules to large proteins (with

or without nano-particle encapsulation) through biological tissues by an innovative  

 combination of nanotechnology and ultrasound ^* .   

* (patent PCT/AU2007/000843)

Advantages

Our technology:

•  removes the risks and discomfort associated with injections;

• depending on the site of application, can be used for targeted or systemic drug delivery; and

• may offer new opportunities for drugs that:

 – are inactivated by gastro-intestinal or liver metabolism; or

 – cause untoward side effects from ingestion.

How it works:

Seagull Technology utilises the electrical properties of polymers combined with ultrasonic

stimulation to facilitate the release of drugs (with or without nano-particle encapsulation)

in regulated doses and subsequent movement of packaged or raw drugs across biological

membranes.

Penetration of drugs coated in nanoparticles      E.M. Ultrastructure of electroconductive polymer

  Click here for an animated demonstration.